A history of AIDS: Looking back to see ahead

被引：83

作者：

Greene, Warner C. ^{[1
]}

机构：

[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA USA

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2007年 / 37卷

关键词：

AIDS; drug design/discovery; global pandemic; HIV; infectious diseases;

D O I：

10.1002/eji.200737441

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Since breaking onto the scene 26 years ago, HIV has proven an indefatigable foe. Over 60 million people have been infected with this retrovirus, and 25 million have already died of AIDS. HIV infection is hitting the hardest in the developing world [1]. Tragically, 1600 babies continue to acquire HIV every day from their infected mothers. Over 12 million children have also been orphaned by AIDS, and this number will likely double by 2010. With these sobering statistics as a backdrop, this feature traces the history of the devastating HIV/AIDS pandemic and offers a view for what the future may hold.

引用

页码：S94 / S102

页数：9

共 46 条

[1] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].

BARRESINOUSSI, F ;

CHERMANN, JC ;

REY, F ;

NUGEYRE, MT ;

CHAMARET, S ;

GRUEST, J ;

DAUGUET, C ;

AXLERBLIN, C ;

VEZINETBRUN, F ;

ROUZIOUX, C ;

ROZENBAUM, W ;

MONTAGNIER, L .

SCIENCE, 1983, 220 (4599) :868-871

[2] The challenge of viral reservoirs in HIV-1 infection [J].

Blankson, JN ;

Persaud, D ;

Siliciano, RF .

ANNUAL REVIEW OF MEDICINE, 2002, 53 :557-593

[3] Microbial translocation is a cause of systemic immune activation in chronic HIV infection [J].

Brenchley, Jason M. ;

Price, David A. ;

Schacker, Timothy W. ;

Asher, Tedi E. ;

Silvestri, Guido ;

Rao, Srinivas ;

Kazzaz, Zachary ;

Bornstein, Ethan ;

Lambotte, Olivier ;

Altmann, Daniel ;

Blazar, Bruce R. ;

Rodriguez, Benigno ;

Teixeira-Johnson, Leia ;

Landay, Alan ;

Martin, Jeffrey N. ;

Hecht, Frederick M. ;

Picker, Louis J. ;

Lederman, Michael M. ;

Deeks, Steven G. ;

Douek, Daniel C. .

NATURE MEDICINE, 2006, 12 (12) :1365-1371

[4]

Centers for Disease Control (CDC), 1982, MMWR-MORBID MORTAL W, V31, P652

[5]

COFFIN J, 1986, NATURE, V321, P10

[6] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].

CONNOR, EM ;

SPERLING, RS ;

GELBER, R ;

KISELEV, P ;

SCOTT, G ;

OSULLIVAN, MJ ;

VANDYKE, R ;

BEY, M ;

SHEARER, W ;

JACOBSON, RL ;

JIMENEZ, E ;

ONEILL, E ;

BAZIN, B ;

DELFRAISSY, JF ;

CULNANE, M ;

COOMBS, R ;

ELKINS, M ;

MOYE, J ;

STRATTON, P ;

BALSLEY, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180

[7]

Cooper D A, 1996, AIDS, V10 Suppl A, pS133

[8] THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].

DALGLEISH, AG ;

BEVERLEY, PCL ;

CLAPHAM, PR ;

CRAWFORD, DH ;

GREAVES, MF ;

WEISS, RA .

NATURE, 1984, 312 (5996) :763-767

[9] Identification of a major co-receptor for primary isolates of HIV-1 [J].

Deng, HK ;

Liu, R ;

Ellmeier, W ;

Choe, S ;

Unutmaz, D ;

Burkhart, M ;

DiMarzio, P ;

Marmon, S ;

Sutton, RE ;

Hill, CM ;

Davis, CB ;

Peiper, SC ;

Schall, TJ ;

Littman, DR ;

Landau, NR .

NATURE, 1996, 381 (6584) :661-666

[10] HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].

Dragic, T ;

Litwin, V ;

Allaway, GP ;

Martin, SR ;

Huang, YX ;

Nagashima, KA ;

Cayanan, C ;

Maddon, PJ ;

Koup, RA ;

Moore, JP ;

Paxton, WA .

NATURE, 1996, 381 (6584) :667-673

← 1 2 3 4 5 →